Etiology of viral induced acute liver failure and defensins as potential therapeutic agents in ALF treatment

CC BY Logo DOI

Acute liver failure (ALF) is a rare and severe disease, which, despite continuous advances in medicine, is still characterized by high mortality (65-85%). Very often, a liver transplant is the only effective treatment for ALF. Despite the implementation of prophylactic vaccinations in the world, the viral background of ALF is still a problem and leads to many deaths. Depending on the cause of ALF, it is sometimes possible to reverse this condition with appropriate therapies, which is why the search for effective antiviral agents seems to be a very desirable direction of research. Defensins, which are our natural antimicrobial peptides, have a very high potential to be used as therapeutic agents for infectious liver diseases. Previous studies on the expression of human defensins have shown that increased expression of human α and β-defensins in HCV and HBV infections is associated with a better response to treatment. Unfortunately, conducting clinical trials for ALF is very difficult due to the severity of the disease and the low incidence, therefore animal models are important for the development of new therapeutic strategies. One of the best animal models that has real reference to research on acute liver failure (ALF) is rabbit hemorrhagic disease in rabbits caused by the Lagovirus europaeus virus. So far, there have been no studies on the potential of defensins in rabbits infected with Lagovirus europaeus virus.

Tytuł
Etiology of viral induced acute liver failure and defensins as potential therapeutic agents in ALF treatment
Twórca
Hrynkiewicz Rafał ORCID 0000-0002-0688-6928
Słowa kluczowe
acute liver failure (ALF); defensin; animal model; Lagovirus europaeus; rabbit hemorrhagic disease; potential therapeutic agent; antimicrobial peptides (AMPs); rabbit defensins
Słowa kluczowe
ostra niewydolność wątroby (ALF); defensyna; model zwierzęcy; krwotoczna choroba królików; potencjalny środek terapeutyczny; peptydy przeciwdrobnoustrojowe (AMP); defensyny królików
Współtwórca
Niedźwiedzka-Rystwej Paulina ORCID 0000-0003-4065-3842
Data
2023
Typ zasobu
artykuł
Identyfikator zasobu
DOI 10.3389/fimmu.2023.1153528
Źródło
Frontiers in Immunology, 2023, vol. 14 nr 1153528, s.1-10, 1153528
Język
angielski
Prawa autorskie
CC BY CC BY
Dyscyplina naukowa
Nauki biologiczne; Dziedzina nauk ścisłych i przyrodniczych
Kategorie
Publikacje pracowników US
Data udostępnienia27 lip 2023, 11:33:19
Data mod.27 lip 2023, 11:33:19
DostępPubliczny
Aktywnych wyświetleń0